Hepatitis B virus escape mutants induced by antiviral therapy.
about
Chronic Hepatitis B with Spontaneous Severe Acute ExacerbationOverview of hepatitis B virus mutations and their implications in the management of infectionThe Role of Oxidative Stress and Antioxidants in Liver DiseasesWhy are there different dynamics in the selection of drug resistance in HIV and hepatitis B and C viruses?Genetic Characterization of Hepatitis B Virus in Peripheral Blood Leukocytes: Evidence for Selection and Compartmentalization of Viral Variants with the Immune Escape G145R MutationKey role of hepatitis B virus mutation in chronic hepatitis B development to hepatocellular carcinomaCharacterization of treatment-naive HIV/HBV co-infected patients attending ART clinic of a tertiary healthcare centre in eastern IndiaPre-existing mutations in reverse transcriptase of hepatitis B virus in treatment-naive Chinese patients with chronic hepatitis BLlama-derived single domain antibodies to build multivalent, superpotent and broadened neutralizing anti-viral moleculesGlobal control of hepatitis B virus: does treatment-induced antigenic change affect immunization?Molecular characterization of intrahepatic and extrahepatic hepatitis B virus (HBV) reservoirs in patients on suppressive antiviral therapy.Occult hepatitis B virus infection in anti-HBs-positive infants born to HBsAg-positive mothers in China.Ultradeep Sequencing for Detection of Quasispecies Variants in the Major Hydrophilic Region of Hepatitis B Virus in Indonesian Patients.Naturally occurring hepatitis B virus surface antigen mutant variants in Malaysian blood donors and vaccinees.Ultra-deep pyrosequencing of hepatitis B virus quasispecies from nucleoside and nucleotide reverse-transcriptase inhibitor (NRTI)-treated patients and NRTI-naive patients.Hepatitis B, C, and D and HIV infections among immigrants from Equatorial Guinea living in SpainHigh-dose hepatitis B immunoglobulin therapy in hepatocellular carcinoma with hepatitis B virus-DNA/hepatitis B e antigen-positive patients after living donor liver transplantation.A function essential to viral entry underlies the hepatitis B virus "a" determinant.Genotyping and Mutation Pattern in the Overlapping MHR Region of HBV Isolates in Southern Khorasan, Eastern Iran.Epidemiology of HBV S-gene mutants in the Liguria Region, Italy: Implications for surveillance and detection of new escape variants.Detection of lamivudine-resistant variants and mutations related to reduced antigenicity of HBsAg in individuals from the cities of Santos and São Paulo, Brazil.Molecular methods in the diagnosis and management of chronic hepatitis B.Management and treatment of chronic hepatitis B in HIV-positive patients.Potential mutations associated with occult hepatitis B virus status.Advances in treating drug-resistant hepatitis B virus in HIV-infected patients.Lamivudine resistance in children with chronic hepatitis B.Impacts of the G145R Mutation on the Structure and Immunogenic Activity of the Hepatitis B Surface Antigen: A Computational AnalysisLamivudine resistance mutations in European patients with hepatitis B and patients co-infected with HIV and hepatitis B.Differential impact of immune escape mutations G145R and P120T on the replication of lamivudine-resistant hepatitis B virus e antigen-positive and -negative strains.Genotyping of HBV and tracking of resistance mutations in treatment-naïve patients with chronic hepatitis B.Reactivation of resolved infection with the hepatitis B virus immune escape mutant G145R during dasatinib treatment for chronic myeloid leukemia.Hepatitis B virus (HBV) variants fluctuate in paired plasma and peripheral blood mononuclear cells among patient cohorts during different chronic hepatitis B (CHB) disease phases.Snapshot on drug-resistance rate and profiles in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice.Molecular analysis of the hepatitis B virus presurface and surface gene in patients from eastern China with occult hepatitis B.Molecular characterization of hepatitis B virus in Bangladesh reveals a highly recombinant population.Mutations in the S gene region of hepatitis B virus genotype D in Golestan Province-Iran.Hepatitis B virus drug resistance to current nucleos(t)ide analogs: Mechanisms and mutation sites.Discrepancy of potential antiviral resistance mutation profiles within the HBV reverse transcriptase between nucleos(t)ide analogue-untreated and -treated patients with chronic hepatitis B in a hospital in China.Why does drug resistance readily evolve but vaccine resistance does not?Naturally occurring hepatitis B virus reverse transcriptase mutations related to potential antiviral drug resistance and liver disease progression.
P2860
Q26772036-C427785C-C40D-4C7C-AB67-86BEDADECB05Q26772346-F11DD5F9-5AA5-4C28-9577-B356334DDDE1Q26779146-EFF0B60D-E035-40A6-99AD-15D6B7F92BBEQ27487167-C7E6E5EB-EB33-4511-92C8-D923685F3BABQ27489690-D7756FAD-B200-4E5A-ADDA-8B707AE89998Q28084458-C0F71C04-95D4-4234-9DA9-5D76EF7A80FBQ28536346-E0F1D912-3B83-4CA2-84B7-D8DD441D7C0AQ28545179-CDAEE73C-0929-4C6A-8ACF-28A175114F5AQ28741431-215737CF-D194-4741-8ED5-2CC0B8E2779DQ33574740-F86BAC4C-A876-4F61-8557-CA6E7F8051B8Q34080966-B76E0CC4-6E19-4F6D-AFC1-F5FBF141E052Q34947605-30936FAE-6C32-464D-92C8-EDA9C85AF211Q35706679-F9780313-639F-4ACF-BFE3-493A6463E03AQ35762179-77EB826A-70D5-4162-894A-72001E9B577DQ35964704-B6D72A92-7B57-4CCE-B77F-AF713C6D2E0CQ36743921-ACFF417F-9B1B-43FF-BB37-7AE7B4B69738Q36747829-7BF3B1D1-D656-4A64-A047-FBA44EC2816DQ37333982-7A707BC9-60EE-4FA8-9069-5D3B4938C059Q37417336-FFF3232E-F00C-4356-AAA1-A7DEA98F3463Q37478309-0B7057EF-3F23-413D-A3F5-B7467229990BQ37502756-DF9D0DB6-0ED5-475E-A3B1-D5D6BADAE1D8Q37801940-3590C9C4-0C11-408B-BF54-430ACEEE145AQ38203324-F309E95A-AEA3-4FD7-97F6-DB0DC62FA824Q38211852-7DBA6564-443D-4E35-A744-24BD84E2419EQ38296047-CDDFAC55-0062-44A3-AA4D-C02B8D35880CQ38456918-E8687F8B-B948-4A18-A6F0-8F9D973A0722Q39375780-B566D223-DC0A-4AA0-9E00-3431C799E077Q39707885-A3169AB1-C6C2-418F-9514-1F3BD8A0DE5BQ39778916-94CB74B9-5D83-4A98-9572-02EF232E94D1Q40109822-7EF8C1B0-7EB3-4F12-8DBD-A7AA36179DC5Q41356321-5D5AC74E-0882-414B-A9FC-D53DC7202E7EQ41746406-5668C28D-3A1B-4317-BEDE-FD18380E9C9BQ44047772-FFC79B0D-C226-48EA-AF0C-9EB7521F9C7CQ44150241-5DBFACC9-D59D-490B-B622-6026E5E7FE40Q45323648-11F6A27B-868C-4A95-A424-0A0A0C07546DQ45360174-1B1B50E4-85BD-462A-A487-03310FEE0D34Q45363333-0E33989C-874F-4648-B04C-E748228CD278Q48053718-C6464760-C8EE-414D-B5FC-9DCDD91B3970Q51219718-63CC02B3-AC92-4CE3-8ED5-CA334F2D6D50Q55019535-E9B2964A-D214-49FA-A5CA-76B02BE22D81
P2860
Hepatitis B virus escape mutants induced by antiviral therapy.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Hepatitis B virus escape mutants induced by antiviral therapy.
@en
Hepatitis B virus escape mutants induced by antiviral therapy.
@nl
type
label
Hepatitis B virus escape mutants induced by antiviral therapy.
@en
Hepatitis B virus escape mutants induced by antiviral therapy.
@nl
prefLabel
Hepatitis B virus escape mutants induced by antiviral therapy.
@en
Hepatitis B virus escape mutants induced by antiviral therapy.
@nl
P356
P1476
Hepatitis B virus escape mutants induced by antiviral therapy.
@en
P304
P356
10.1093/JAC/DKN014
P407
P577
2008-01-24T00:00:00Z